Olive and Ibu drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Olive (olive) and Ibu (ibuprofen). Common drug interactions include throat irritation among females and acute respiratory distress syndrome among males.

The phase IV clinical study analyzes what interactions people have when they take Olive and Ibu. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Olive?

Olive has active ingredients of olive. eHealthMe is studying from 816 Olive users. Check the latest studies of Olive.

What is Ibu?

Ibu has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 246,532 Ibu users. Check the latest studies of Ibu.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

44 people who take Olive and Ibu together, and have interactions are studied.

Olive and Ibu drug interactions.

What are the common drug interactions of Olive and Ibu, by gender? *:

female:

  1. Throat irritation
  2. Thrombosis (formation of a blood clot inside a blood vessel)
  3. Tonsillar disorder (disease of tonsil)
  4. Weight increased
  5. Hallucination, visual (seeing things that aren't there)
  6. Mobility decreased (ability to move is reduced)
  7. Depression
  8. Dizziness
  9. Hyperhidrosis (abnormally increased sweating)
  10. Mood altered (changes in mood)

male:

  1. Acute respiratory distress syndrome
  2. Anaemia (lack of blood)
  3. Gastric ulcer haemorrhage (bleeding ulcer of stomach)
  4. Hypotension (abnormally low blood pressure)
  5. Oral discharge
  6. Respiratory distress (difficulty in breathing)
  7. Respiratory tract congestion (blockage on respiratory system)
  8. Swelling face
  9. Umbilical hernia (an outward bulging (protrusion) of the abdominal lining or part of the abdominal organ(s) through the area around the belly button)
  10. Weight gain poor

What are the common drug interactions of Olive and Ibu, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Device dislocation
  2. Umbilical hernia (an outward bulging (protrusion) of the abdominal lining or part of the abdominal organ(s) through the area around the belly button)
  3. Weight gain poor

10-19:

  1. Abdominal distension
  2. Abdominal pain
  3. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  4. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  5. Throat irritation
  6. Tonsillar disorder (disease of tonsil)

20-29:

  1. Swelling face

30-39:

  1. Acute respiratory distress syndrome
  2. Dermatitis bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid)
  3. Erythema (redness of the skin)
  4. Pruritus (severe itching of the skin)

40-49:

  1. Anaemia (lack of blood)
  2. Circulatory collapse
  3. Gastric ulcer haemorrhage (bleeding ulcer of stomach)
  4. Hypotension (abnormally low blood pressure)
  5. Nasopharyngitis (inflammation of the nasopharynx)

50-59:

  1. Pain in extremity

60+:

  1. Hallucination, visual (seeing things that aren't there)
  2. Mobility decreased (ability to move is reduced)
  3. Bone pain
  4. Chest pain
  5. Chills (felling of cold)
  6. Chronic kidney disease
  7. Constipation
  8. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  9. Cough
  10. Death

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 10 people, 22.73%
  2. Muscle Spasms (muscle contraction): 5 people, 11.36%
  3. Respiratory Disorder (respiratory disease): 4 people, 9.09%
  4. Nervous System Disorder (a general class of medical conditions affecting the nervous system): 4 people, 9.09%
  5. Constipation: 3 people, 6.82%
  6. Chronic Inflammatory Demyelinating Polyradiculoneuropathy (long lasting infection of nerves outside brain and spinal cord): 3 people, 6.82%
  7. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 6.82%
  8. Abdominal Pain: 3 people, 6.82%

* Approximation only. Some reports may have incomplete information.

Do you take Olive and Ibu?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Olive and Ibu:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Olive:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ibu:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Olive and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ibu and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on olive and ibuprofen (the active ingredients of Olive and Ibu, respectively), and Olive and Ibu (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: